Molecular and cellular morphology of placenta unveils new mechanisms of reproductive immunology.

J Adv Res

Jinxin Research Institute for Reproductive Medicine and Genetics, Sichuan Jinxin Xi'nan Women's and Children's Hospital, Chengdu, China; Provincial Key Laboratory of Molecular Pathology and Personalized Medicine, Center of Collaborative and Creative Center, Department of Pathology and Pathophysiolog

Published: January 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Despite of numerous studies of the placenta, some molecular and cellular characteristics, particularly the relationship among different cell types, have not been well understood. We aim to investigate the basic and intricate details of cellular and molecular elements in early and late phase placentas to gain better understanding of the immune regulation of human reproductive process.

Methods: A novel combination of techniques of spatial transcriptomics(ST), multiple immunohistochemistry, and a dual labeling combining immunohistochemistry and (fluorescence in situ hybridization) FISH on normal and ectopic pregnancy and animal models was employed to investigate the placenta at tissue, cell, protein and molecular levels and to trace the fetal and maternal origin of every cell in early and late placentas.

Results: Original discoveries include early expression of immune checkpoint proteins in embryo trophoblasts even before implantation. The detailed distributional relationships among different cell types of fetal and maternal origins in placenta and decidua indicate an immune rejection of the mother towards the fetus and this was counterbalanced by immune inhibitory proteins and blocking antibody Immunoglobulin G4 (IgG4) at the junction between the fetus and the mother. In contrary to common believe, we found that vascular endothelial and glandular epithelial cells in the decidua remain maternal in origin and were not replaced by fetal cells. At term placenta, fetal immune cells infiltrated into the maternal side of the decidus and vice versa indicating a possible immune reaction between fetal and maternal immune systems and suggesting a possible immune mechanism for trigger of parturition. The ability of trophoblasts to create an immune suppressed environment was also supported by findings in ectopic pregnancy and the animal models.

Conclusion: The findings indicate a fetus-driven mechanism of immune balance involving both cellular and humoral immunity in human reproduction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jare.2025.01.025DOI Listing

Publication Analysis

Top Keywords

fetal maternal
12
immune
10
molecular cellular
8
cell types
8
early late
8
ectopic pregnancy
8
pregnancy animal
8
maternal origin
8
placenta
5
fetal
5

Similar Publications

Tremendous advances in ultrasound equipment and knowledge have expanded possibilities for the first trimester detailed ultrasound examination. Recommendations from national organizations to offer this service to patients with indications, coupled with recent modifications for dual use of the current procedural terminology code 76811 during pregnancy, will result in increased demand from patients and referring physicians. While proper reimbursement may motivate healthcare professionals to incorporate the first trimester detailed ultrasound examination into their practice and raise the standards of care in the first trimester, it can also be a challenging transition.

View Article and Find Full Text PDF

Sigmoid volvulus and uterine torsion are both rare and challenging conditions in pregnancy, and the coexistence of these conditions is particularly difficult to diagnose. Herein, we report a case of a 38-year-old pregnant woman at 30 weeks of gestation, with a history of two prior cesarean sections, who presented with severe abdominal pain, vomiting, and constipation, and was eventually diagnosed with both sigmoid volvulus and uterine torsion during surgery. Clinicians should consider the possibility of bowel obstruction when a pregnant woman presents with severe abdominal pain, vomiting, and constipation, as early diagnosis is crucial.

View Article and Find Full Text PDF

Burden and trends of ovarian and uterine cancer due to high body mass index from 1990 to 2021: an age-period-cohort study based on the GBD 2021, and projections through 2036.

Front Oncol

August 2025

Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

Background: Ovarian cancer (OC) and uterine cancer (UC) are significant public health concerns among women of reproductive age. High body mass index (BMI) contributes to the increasing burden of these cancers globally, but comprehensive epidemiological assessments remain limited.

Methods: Data were obtained from the Global Burden of Disease (GBD) Study 2021 (1990-2021).

View Article and Find Full Text PDF

Study Question: What is the effect of hCG on the epigenetic profile and the expression of other molecular factors in endometrial stromal cells (ESCs)?

Summary Answer: Our findings suggest that hCG treatment alters the molecular environment of decidualized ESCs, potentially influencing implantation and immune regulation through epigenetic modifications and changes in the levels of secreted proteins and micro-ribonucleic acids (miRNAs).

What Is Known Already: Embryo implantation depends not only on the quality of the embryo but also on the receptivity of the endometrium, the specialized lining of the uterus that undergoes dynamic changes to support pregnancy. Effective communication between the maternal and fetal compartments, facilitated by molecular signals and cellular interactions, is essential for successful implantation.

View Article and Find Full Text PDF

Objective: To report the incidence and survival patterns for children, adolescents, and young adults (CAYA) cancer survivors over the past 20 years.

Methods: CAYA (under 25 years old) cancer survivors from 17 Surveillance, Epidemiology, and End Results (SEER) registries from 2000 to 2020 were analyzed. A joinpoint regression model was used to analyze the incidence and 5-year survival rate.

View Article and Find Full Text PDF